The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PROLYLHYDROXYLASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009134850A1
公开(公告)日:2009-11-05
The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.